PMD Psychemedics Corp.

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek has joined the Company as Vice President, Controller.

In this important role, Andrew will be responsible for directing and managing all of the Company’s financial activities including external reporting and internal analysis. He will report directly to the Company’s CEO.

As an active CPA, Andrew joins the Company with over 12 years-experience and a very strong accounting technical background, having worked at three high level accounting advisory firms. In addition, Andrew has had several operational roles including role of Controller at Racepoint Global, Inc., an international, independent professional services agency. Most recently, Andrew has been a consultant as a financial planning and analysis Director at a publicly-held biotech company. Andrew graduated from University of New Hampshire with a Bachelor of Science degree in Accounting.

Raymond C. Kubacki, Chairman and CEO of Psychemedics, stated “We are extremely pleased to have Andrew joining our team and heading up this important area in our Company. Andrew’s strong technical accounting background and experience are very important as we address today’s increasingly complex accounting world. In addition, his significant financial analysis skills and background will be a great contribution to the Company’s growth strategy and plans. We are excited to have him on board.”

Psychemedics Corporation is the world’s largest provider of hair testing for the detection of drugs of abuse. The Company’s patented process is used by thousands of U.S. and international clients, including over 10% of the Fortune 500 companies, for pre-employment and random drug testing. Major police departments, Federal Reserve Banks, schools, and other public entities also rely on our unique patented drug testing process. We strongly believe our drug testing method to be superior to any other product currently in use, including traditional urine testing and other hair testing methods. The Psychemedics web site is .

Contact: Raymond C. Kubacki, Chairman, President and CEO

Phone: (978) 206-8220



EN
26/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Psychemedics Corp.

 PRESS RELEASE

Psychemedics Releases 2025 Workforce Insights Report

Psychemedics Releases 2025 Workforce Insights Report Synthetic Drug Threats and Legalization Risks Shape a New Era for Workplace Safety DALLAS, June 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair testing for drugs of abuse, today announced the release of its second annual Workforce Insights Report, providing a comprehensive look at the evolving drug landscape and its impact on workplace safety, hiring practices, and employer risk. The 2025 Psychemedics Insights Report draws from the largest proprietary database of hair drug testing results in the industr...

 PRESS RELEASE

Psychemedics Named “Most Innovative Drug Testing Company of the Year”

Psychemedics Named “Most Innovative Drug Testing Company of the Year” DALLAS, May 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s leading provider of hair drug testing, is proud to announce it has been named “Most Innovative Drug Testing Company of the Year” by Acquisition International Magazine as part of its prestigious 2025 Global Excellence Awards. This recognition honors Psychemedics’ continued leadership in advancing the science of drug detection, including the recent launch of its Enhanced Quartile Reporting. This breakthrough analytics tool provides deeper insi...

 PRESS RELEASE

Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced D...

Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights DALLAS, March 03, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair drug testing, is proud to announce the launch of its innovative Quartile Reporting feature. This industry-first enhancement empowers organizations with unprecedented insights into drug test results, enabling data-driven decision-making and fostering safer, more productive workplaces. The new Quartile Reporting feature allows clients to see where a candidate’s or employee’s test results fall within a range o...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 14, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch